Boussard & Gavaudan Investment Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.8M 7.0k 1110.92

More positions owned by Boussard & Gavaudan Investment Management

Axon Enterprise Note 0.500%12/1
Microsoft Corporation (MSFT)
Apple (AAPL)
Insmed Note 0.750% 6/0
NVIDIA Corporation (NVDA)
Ionis Pharmaceuticals Note 4/0
Etsy Note 0.125%10/0
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Hess (HES)
Integer Hldgs Corp Note 2.125% 2/1
Ansys (ANSS)
Altair Engr Note 1.750% 6/1
Costco Wholesale Corporation (COST)
Freshpet Note 3.000% 4/0

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Camden Asset Management
Lazard Asset Management
Millennium Management
MacKay Shields
Advent Capital Management
Calamos Advisors
Citadel Advisors
Wolverine Asset Management
Bank Of Montreal
Glazer Capital
State Street Corporation
CNH Partners
DeepCurrents Investment Group
BlackRock

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1